Revvity RVTY 深 沪
已收盘 09-11 16:00:00 美东时间
124.31
+3.370
+2.79%
华盛通- 最 高124.65
- 今 开122.40
- 成交量 115.15万股
- 最 低 121.61
- 昨 收 120.94
- 总市值 138.71亿
- 52周最高 133.00
- 市盈率 静 59.89
- 换手率 1.03%
- 52周最低 81.15
- 委 比 42.86%
- 总股本 1.12亿
- 历史最高 201.83
- 量 比 0.75
- 振 幅 2.51%
- 历史最低 13.95
- 每 手 1
- 风险率 11.33%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 戴尔、Adobe获大行上调目标价；甲骨文绩前目标价遭调低
今日重点评级关注：富国银行：维持Pyxis Oncology"超配"评级，目标价从12美元升至19美元；Oppenheimer：维持Opus Genetics"跑赢大市"评级，目标价从10美元升至20美元
09-10 15:00
UBS Assumes Revvity at Neutral, Raises Price Target to $140
UBS analyst Doug Schenkel assumes Revvity (NYSE:RVTY) with a Neutral rating and raises Price Target to $140.
09-09 21:57
Revvity to acquire Human Cell Design
Revvity (RVTY) to acquire France-based Human Cell Design, a biotechnology company focused on human cell models for diabetes, obesity and other metabolic diseases. The financial terms were not disclose...
09-09 18:48
Revvity To Acquire French Biotech Firm Human Cell Design To Gain Exposure To Human Cell Models And Preclinical Research Solutions For Diabetes, Obesity And Other Metabolic Diseases
The acquisition is expected to add HCD’s human pancreatic beta cell models to Revvity’s Life Sciences portfolio, supporting drug discovery, screening and preclinical research, including applications in GLP-1 and other metabolic disease therapies. The transaction is expected to close in Q4 2026 and ...
09-09 18:09
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks
The healthcare sector (XLV) gained 4.91% in August, outperforming the broader S&P 500 (SPY), which advanced 2.68% during the month. Healthcare stocks benefited from strength in biotechnology and medic...
09-05 23:05
美股大行评级 | 美银上调微软目标价从500美元升至600美元；BlossomHill获小摩等多家大行首予买入评级
今日重点评级关注：BTIG：维持Kazia Therapeutics"买入"评级，目标价从34美元升至40美元；摩根大通：维持Annexon"超配"评级，目标价从10美元升至14美元
09-02 14:07
RBC Capital Initiates Coverage On Revvity with Sector Perform Rating, Announces Price Target of $135
RBC Capital analyst Dan Leonard initiates coverage on Revvity (NYSE:RVTY) with a Sector Perform rating and announces Price Target of $135.
09-01 20:03
Notable healthcare headlines for the week: Veeva Systems, Boston Scientific in focus
Wall Street ended Friday's session modestly lower as traders digested Federal Reserve Chair Kevin Warsh's speech at the Jackson Hole Symposium. The S&P 500 slipped 0.25%, the Dow was almost flat, and ...
08-30 21:05
财报速睇 | Revvity, Inc. 2026财年Q3营收7.30亿美元，同比增长1.3%；归母净利润0.52亿美元，同比下滑3.9%
华盛资讯8月12日讯，Revvity, Inc.公布2026财年Q3业绩，公司Q3营收7.30亿美元，同比增长1.3%，归母净利润0.52亿美元，同比下滑3.9%。
08-12 04:17
公司简介
公司名称
|
Revvity
|
行业分类
|
--
|
业务描述
|
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.
|
美股大行评级 | 戴尔、Adobe获大行上调目标价；甲骨文绩前目标价遭调低
今日重点评级关注：富国银行：维持Pyxis Oncology"超配"评级，目标价从12美元升至19美元；Oppenheimer：维持Opus Genetics"跑赢大市"评级，目标价从10美元升至20美元
09-10 15:00
UBS Assumes Revvity at Neutral, Raises Price Target to $140
UBS analyst Doug Schenkel assumes Revvity (NYSE:RVTY) with a Neutral rating and raises Price Target to $140.
09-09 21:57
Revvity to acquire Human Cell Design
Revvity (RVTY) to acquire France-based Human Cell Design, a biotechnology company focused on human cell models for diabetes, obesity and other metabolic diseases. The financial terms were not disclose...
09-09 18:48
Revvity To Acquire French Biotech Firm Human Cell Design To Gain Exposure To Human Cell Models And Preclinical Research Solutions For Diabetes, Obesity And Other Metabolic Diseases
The acquisition is expected to add HCD’s human pancreatic beta cell models to Revvity’s Life Sciences portfolio, supporting drug discovery, screening and preclinical research, including applications in GLP-1 and other metabolic disease therapies. The transaction is expected to close in Q4 2026 and ...
09-09 18:09
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks
The healthcare sector (XLV) gained 4.91% in August, outperforming the broader S&P 500 (SPY), which advanced 2.68% during the month. Healthcare stocks benefited from strength in biotechnology and medic...
09-05 23:05
美股大行评级 | 美银上调微软目标价从500美元升至600美元；BlossomHill获小摩等多家大行首予买入评级
今日重点评级关注：BTIG：维持Kazia Therapeutics"买入"评级，目标价从34美元升至40美元；摩根大通：维持Annexon"超配"评级，目标价从10美元升至14美元
09-02 14:07
RBC Capital Initiates Coverage On Revvity with Sector Perform Rating, Announces Price Target of $135
RBC Capital analyst Dan Leonard initiates coverage on Revvity (NYSE:RVTY) with a Sector Perform rating and announces Price Target of $135.
09-01 20:03
Notable healthcare headlines for the week: Veeva Systems, Boston Scientific in focus
Wall Street ended Friday's session modestly lower as traders digested Federal Reserve Chair Kevin Warsh's speech at the Jackson Hole Symposium. The S&P 500 slipped 0.25%, the Dow was almost flat, and ...
08-30 21:05
财报速睇 | Revvity, Inc. 2026财年Q3营收7.30亿美元，同比增长1.3%；归母净利润0.52亿美元，同比下滑3.9%
华盛资讯8月12日讯，Revvity, Inc.公布2026财年Q3业绩，公司Q3营收7.30亿美元，同比增长1.3%，归母净利润0.52亿美元，同比下滑3.9%。
08-12 04:17
派息除权日
|
每股总股息
| 派息日期 |
2026-10-23
|
0.07
|
2026-11-13
|
2026-07-17
|
0.07
|
2026-08-07
|
2026-04-17
|
0.07
|
2026-05-08
|
2026-01-16
|
0.07
|
2026-02-06
|
2025-10-17
|
0.07
|
2025-11-07
|
2025-07-18
|
0.07
|
2025-08-08
|
2025-04-17
|
0.07
|
2025-05-09
|
2025-01-17
|
0.07
|
2025-02-07
|
2024-10-18
|
0.07
|
2024-11-08
|
2024-07-19
|
0.07
|
2024-08-09
|
2024-04-18
|
0.07
|
2024-05-10
|
2024-01-18
|
0.07
|
2024-02-09
|
2023-10-19
|
0.07
|
2023-11-10
|
2023-07-20
|
0.07
|
2023-08-11
|
2023-04-20
|
0.07
|
2023-05-12
|
2023-01-19
|
0.07
|
2023-02-10
|
2022-10-20
|
0.07
|
2022-11-11
|
2022-07-21
|
0.07
|
2022-08-12
|
2022-04-21
|
0.07
|
2022-05-13
|
2022-01-20
|
0.07
|
2022-02-11
|
2021-10-21
|
0.07
|
2021-11-12
|
2021-07-15
|
0.07
|
2021-08-06
|
2021-04-15
|
0.07
|
2021-05-07
|
2021-01-21
|
0.07
|
2021-02-12
|
2020-10-15
|
0.07
|
2020-11-06
|
2020-07-16
|
0.07
|
2020-08-07
|
2020-04-16
|
0.07
|
2020-05-08
|
2020-01-16
|
0.07
|
2020-02-07
|
2019-10-17
|
0.07
|
2019-11-08
|
2019-07-18
|
0.07
|
2019-08-09
|
2019-04-17
|
0.07
|
2019-05-10
|
2019-01-17
|
0.07
|
2019-02-08
|
2018-10-18
|
0.07
|
2018-11-09
|
2018-07-19
|
0.07
|
2018-08-10
|
2018-04-12
|
0.07
|
2018-05-10
|
2018-01-18
|
0.07
|
2018-02-09
|
2017-10-19
|
0.07
|
2017-11-10
|
2017-07-19
|
0.07
|
2017-08-10
|
2017-04-11
|
0.07
|
2017-05-10
|
2017-01-18
|
0.07
|
2017-02-10
|
2016-10-12
|
0.07
|
2016-11-10
|
2016-07-13
|
0.07
|
2016-08-10
|
2016-04-13
|
0.07
|
2016-05-10
|
2016-01-13
|
0.07
|
2016-02-10
|
2015-10-14
|
0.07
|
2015-11-10
|
2015-07-15
|
0.07
|
2015-08-10
|
2015-04-15
|
0.07
|
2015-05-11
|
2015-01-14
|
0.07
|
2015-02-06
|
2014-10-15
|
0.07
|
2014-11-07
|
2014-07-16
|
0.07
|
2014-08-08
|
2014-04-15
|
0.07
|
2014-05-09
|
2014-01-15
|
0.07
|
2014-02-07
|
2013-10-16
|
0.07
|
2013-11-08
|
2013-07-17
|
0.07
|
2013-08-09
|
2013-04-17
|
0.07
|
2013-05-10
|
2013-01-16
|
0.07
|
2013-02-08
|
2012-10-17
|
0.07
|
2012-11-09
|
2012-07-18
|
0.07
|
2012-08-10
|
2011-07-20
|
0.07
|
2011-08-12
|
2011-04-19
|
0.07
|
2011-05-13
|
2011-01-19
|
0.07
|
2011-02-11
|
2010-10-20
|
0.07
|
2010-11-12
|
2010-07-21
|
0.07
|
2010-08-13
|
2010-04-14
|
0.07
|
2010-05-07
|
2010-01-20
|
0.07
|
2010-02-12
|
2009-10-21
|
0.07
|
2009-11-13
|
2009-07-15
|
0.07
|
2009-08-07
|
2009-04-15
|
0.07
|
2009-05-08
|
2009-01-14
|
0.07
|
2009-02-06
|
2008-10-15
|
0.07
|
2008-11-07
|
2008-07-16
|
0.07
|
2008-08-08
|
2008-04-16
|
0.07
|
2008-05-09
|
2008-01-16
|
0.07
|
2008-02-08
|
2007-10-17
|
0.07
|
2007-11-09
|
2007-07-18
|
0.07
|
2007-08-10
|
2007-04-18
|
0.07
|
2007-05-11
|
2007-01-17
|
0.07
|
2007-02-09
|
2006-10-18
|
0.07
|
2006-11-10
|
2006-07-19
|
0.07
|
2006-08-11
|
2006-04-19
|
0.07
|
2006-05-12
|
2006-01-18
|
0.07
|
2006-02-10
|
2005-10-19
|
0.07
|
2005-11-11
|
2005-07-20
|
0.07
|
2005-08-12
|
2005-04-20
|
0.07
|
2005-05-13
|
2005-01-19
|
0.07
|
2005-02-11
|
2004-10-20
|
0.07
|
2004-11-12
|
2004-07-21
|
0.07
|
2004-08-13
|
2004-04-21
|
0.07
|
2004-05-14
|
2004-01-14
|
0.07
|
2004-02-05
|
2003-10-15
|
0.07
|
2003-11-07
|
2003-07-16
|
0.07
|
2003-08-08
|
2003-04-15
|
0.07
|
2003-05-09
|
2003-01-15
|
0.07
|
2003-02-07
|
2002-10-16
|
0.07
|
2002-11-08
|
2002-07-17
|
0.07
|
2002-08-09
|
2002-04-17
|
0.07
|
2002-05-10
|
2002-01-16
|
0.07
|
2002-02-09
|
2001-10-17
|
0.07
|
2001-11-09
|
2001-07-18
|
0.07
|
2001-08-10
|
2001-04-18
|
0.14
|
2001-05-10
|
2001-01-17
|
0.14
|
2001-02-09
|
2000-10-18
|
0.14
|
2000-11-10
|
2000-07-19
|
0.14
|
2000-08-10
|
2000-04-18
|
0.14
|
2000-05-10
|
2000-01-19
|
0.14
|
2000-02-10
|
1999-10-20
|
0.14
|
1999-11-10
|
1999-07-21
|
0.14
|
1999-08-10
|
1999-04-21
|
0.14
|
1999-05-10
|
1999-01-20
|
0.14
|
1999-02-10
|
1998-10-21
|
0.14
|
1998-11-10
|
1998-07-22
|
0.14
|
1998-08-10
|
1998-04-15
|
0.14
|
1998-05-08
|
1998-01-14
|
0.14
|
1998-02-06
|
1997-10-15
|
0.14
|
1997-11-10
|
1997-07-16
|
0.14
|
1997-08-08
|
1997-04-16
|
0.14
|
1997-05-09
|
1997-01-15
|
0.14
|
1997-02-10
|
1996-10-16
|
0.14
|
1996-11-08
|
1996-07-17
|
0.14
|
1996-08-09
|
1996-04-17
|
0.14
|
1996-05-10
|
1996-01-17
|
0.14
|
1996-02-09
|
1995-10-18
|
0.14
|
1995-11-10
|
1995-07-19
|
0.14
|
1995-08-10
|
1995-04-17
|
0.14
|
1995-05-10
|
1995-02-14
|
0.010
|
1995-02-14
|
1995-01-13
|
0.14
|
1995-02-10
|
1994-10-17
|
0.14
|
1994-11-10
|
1994-07-18
|
0.14
|
1994-08-10
|
1994-04-18
|
0.14
|
1994-05-10
|
1994-01-14
|
0.14
|
1994-02-10
|
1993-10-18
|
0.13
|
1993-11-10
|
1993-07-19
|
0.13
|
1993-08-10
|
1993-04-12
|
0.13
|
1993-05-07
|
1993-01-15
|
0.13
|
1993-02-10
|
1992-10-19
|
0.13
|
1992-11-10
|
1992-07-13
|
0.13
|
1992-08-07
|
1992-04-10
|
0.25
|
1992-05-08
|
1992-01-13
|
0.23
|
1992-02-07
|
1991-10-11
|
0.21
|
1991-11-08
|
1991-07-15
|
0.21
|
1991-08-09
|
1991-04-15
|
0.21
|
1991-05-10
|
1991-01-14
|
0.21
|
1991-02-08
|
1990-10-15
|
0.19
|
1990-11-09
|
1990-07-16
|
0.19
|
1990-08-10
|
1990-04-16
|
0.19
|
1990-05-10
|
1990-01-12
|
0.19
|
1990-02-09
|
1989-10-16
|
0.17
|
1989-11-10
|
1989-07-17
|
0.17
|
1989-08-10
|
1989-04-17
|
0.17
|
1989-05-10
|
1989-01-13
|
0.17
|
1989-02-10
|
1988-10-25
|
0.15
|
1988-11-10
|
1988-07-18
|
0.15
|
1988-08-10
|
1988-04-18
|
0.15
|
1988-05-10
|
1988-01-15
|
0.15
|
1988-02-10
|
1987-10-19
|
0.14
|
1987-11-10
|
1987-07-20
|
0.14
|
1987-08-07
|
1987-04-10
|
0.14
|
1987-05-08
|
1987-01-16
|
0.14
|
1987-02-10
|
1986-10-10
|
0.13
|
1986-11-07
|
1986-07-14
|
0.13
|
1986-08-08
|
1986-04-14
|
0.13
|
1986-05-09
|
1986-01-13
|
0.13
|
1986-02-07
|
1985-10-11
|
0.12
|
1985-11-08
|
1985-07-15
|
0.12
|
1985-08-09
|
1985-04-15
|
0.12
|
1985-05-10
|
1985-01-14
|
0.12
|
1985-02-08
|
1984-10-15
|
0.10
|
1984-11-09
|
1984-07-16
|
0.10
|
1984-08-10
|
1984-04-13
|
0.10
|
1984-05-10
|
1984-01-16
|
0.10
|
1984-02-10
|
1983-10-17
|
0.09
|
1983-11-10
|
1983-07-18
|
0.09
|
1983-08-10
|
1983-04-18
|
0.09
|
1983-05-10
|
1983-01-17
|
0.09
|
1983-02-10
|
1982-10-18
|
0.08
|
1982-11-10
|
1982-07-12
|
0.08
|
1982-08-02
|
1982-04-12
|
0.08
|
1982-05-03
|
1982-01-04
|
0.16
|
1982-01-08
|
1981-10-09
|
0.13
|
1981-11-02
|
1981-07-13
|
0.13
|
1981-08-03
|
1981-04-10
|
0.13
|
1981-05-01
|
1981-01-12
|
0.13
|
1981-02-02
|
1980-10-10
|
0.10
|
1980-11-03
|
1980-07-14
|
0.10
|
1980-08-01
|
1980-04-07
|
0.10
|
1980-05-01
|
1980-01-07
|
0.20
|
1980-02-01
|
1979-10-05
|
0.15
|
1979-11-01
|
1979-07-09
|
0.15
|
1979-08-01
|
1979-04-06
|
0.15
|
1979-05-01
|
1979-01-08
|
0.15
|
1979-02-01
|
1978-10-06
|
0.11
|
1978-11-01
|
1978-07-10
|
0.11
|
1978-08-01
|
1978-04-10
|
0.11
|
1978-05-01
|
1978-01-09
|
0.09
|
1978-02-01
|
1977-10-07
|
0.09
|
1977-11-01
|
1977-08-08
|
0.09
|
1977-09-01
|
1977-05-09
|
0.09
|
1977-06-01
|
